Piper Sandler raises Fastly target to $8; keeps Neutral rating. Fastly's Q3 EPS beats estimates, revenue slightly misses ...

Under Trump, bank deal approvals are likely to “speed up markedly and the process will be more clearly delineated,” one ...

Piper Sandler raised the firm’s price target on Upwork (UPWK) to $18 from $13 and keeps an Overweight rating on the shares. The firm says ...

Fastly (NYSE:FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped ...

Piper Sandler analysts on Thursday cut their rating on HubSpot (NYSE:HUBS) shares to Neutral from Overweight, while raising the price target from $570 to $640. The investment bank acknowledged the ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Pacira Pharmaceuticals (PCRX – Research Report), with a price target of $12.00. The company’s shares closed ...

“We are confident that the regulatory pendulum will swing back somewhat,” Mark Fitzgibbon, an analyst at Piper Sandler, said ...

The British drugmaker’s unit RBP Global Holdings Ltd. signed up with Piper Sandler Finance LLC and certain buyers for $400 ...

Such findings raised questions about the added benefit of masofaniten, leading ESSA to abandon the drug’s development. In light of these results, Piper Sandler removed any projected value for ...

Ann Miller will lead global sports marketing, and Chief Supply Chain Officer Venkatesh Alagirisamy will be elevated to the ...

On Thursday, Karyopharm Therapeutics Inc (KPTI) stock saw a modest uptick, ending the day at $0.99 which represents a slight increase of $0.15 or 17.86% from the prior close of $0.84. The stock opened ...

Microsoft stock fell after guidance disappointed investors. Analysts see strong demand and AI revenue opportunities for the future.